Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Sayf A Yassin; Vanita R Aroda

doi:10.2147/DDDT.S121899

open access to scientific and medical research

Back to Journals » Drug Design, Development and Therapy » Volume 11

Review

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Total article views		HTML views	PDF downloads	Totals
14,010	Dovepress*	11,976+	1,630	13,606
	PubMed Central*	2,034	418	2,452
	Totals	14,010	2,048	16,058
*Since 21 March 2017

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.